Skip to content

Clinical trials

Epstein-Barr Virus Infections trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epstein-Barr Virus Infections Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20131
20141
20152
20172
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated3
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto2
AlloVir1
Atara Biotherapeutics1
Celgene1
Dr. Jean-Sebastien Delisle, MD, PhD1
Marengo Therapeutics, Inc.1
NRG Oncology1
Pierre Fabre Medicament1
St. Justine's Hospital1
Viracta Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epstein-Barr Virus Infections11
Nasopharyngeal Neoplasms3
Head and Neck Neoplasms2
Lymphoproliferative Disorders2
Nasopharyngeal Carcinoma2
Neoplasm Metastasis2
Neoplasms2
Recurrence2
Abdominal Neoplasms1
Adenoviridae Infections1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.